NEXENTIS TECHNOLOGIES INC. Increase Decrease In Operating Lease Liability
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase Decrease In Operating Lease Liability of -$6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$2.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$4.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$3.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$4.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for fiscal 2025 was -$14.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for fiscal 2024 was -$50.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for fiscal 2023 was -$66.00K.
- NEXENTIS TECHNOLOGIES INC. increase decrease in operating lease liability for fiscal 2022 was -$68.86K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.00K 10-Q · filed 2026-08-13 | -$9.00K derived: sum of 3 quarters · filed 2026-08-13 | -$13.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$4.00K 10-Q · filed 2026-05-14 | -$7.00K derived: sum of 2 quarters · filed 2026-05-14 | -$11.00K derived: sum of 3 quarters · filed 2026-05-14 | -$16.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$7.00K derived: sum of 2 quarters · filed 2026-03-31 | -$12.00K derived: sum of 3 quarters · filed 2026-08-13 | -$14.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.00K derived: sum of 2 quarters · filed 2026-08-13 | -$11.00K 10-Q · filed 2025-11-13 | -$17.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$7.00K 10-Q · filed 2026-08-13 | -$13.00K derived: sum of 3 quarters · filed 2026-08-13 | -$26.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$2.00K 10-Q · filed 2026-05-14 | -$8.00K derived: sum of 2 quarters · filed 2026-05-14 | -$21.00K derived: sum of 3 quarters · filed 2026-05-14 | -$37.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$19.00K derived: sum of 2 quarters · filed 2026-03-31 | -$35.00K derived: sum of 3 quarters · filed 2026-03-31 | -$50.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$29.00K derived: sum of 2 quarters · filed 2025-11-13 | -$44.00K 10-Q · filed 2025-11-13 | -$43.72K 10-Q · filed 2024-11-14 | -$56.58K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$31.00K 10-Q · filed 2025-08-14 | -$31.11K 10-Q · filed 2024-08-14 | -$43.58K derived: sum of 3 quarters · filed 2025-08-14 | -$61.70K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$15.00K 10-Q · filed 2025-05-15 | -$15.47K 10-Q · filed 2024-05-15 | -$27.57K derived: sum of 2 quarters · filed 2025-05-15 | -$45.70K derived: sum of 3 quarters · filed 2025-05-15 | -$63.43K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$12.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$30.70K derived: sum of 2 quarters · filed 2025-03-31 | -$48.43K derived: sum of 3 quarters · filed 2025-03-31 | -$66.00K 10-K · filed 2025-03-31 | -$66.30K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$18.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$35.86K derived: sum of 2 quarters · filed 2024-11-14 | -$53.42K 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$17.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$35.30K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$17.57K 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$68.86K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |